InvestorsHub Logo

236T568

06/05/19 1:40 PM

#6540 RE: tradero #6539

actually, wrong - yet again

there are other matters to this company that allows one to call it a scam beyond its research and products

Look deep into ISCO SEC filings and into the backgrounds of the controlling Russian family and you will find your answers



Woww! That is a huge statement and I have not read much reasoning behind it.

I do not think there is any problem with the stem cells ISCO is working with because they are of different kind than those the newspaper you mentioned was talking about.

The big problem with ISCO (and it has always been so) is that the revenues obtained from other ISCO activities can not cover the cost of the trials. Thus the dilution issue

Doctor_Hari_Seldon

06/05/19 4:21 PM

#6541 RE: tradero #6539

Actually Correct.